ADMA BIOLOGICS, INC. Cash And Cash Equivalents At Carrying Value

• ADMA BIOLOGICS, INC. showed a decrease of -15.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from ADMA BIOLOGICS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
• XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2010: $12.0 thousand | Q3 2010: $3.6 thousand | Q1 2011: $81.5 thousand | Q2 2011: $87.8 thousand | Q3 2011: $4.2 thousand | Q1 2012: $14.24 million | Q2 2012: $12.84 million | Q3 2012: $10.72 million | Q1 2013: $10.32 million | Q2 2013: $7.65 million | Q3 2013: $5.38 million | Q1 2014: $26.52 million | Q2 2014: $17.87 million | Q3 2014: $13.95 million | Q1 2015: $16.56 million | Q2 2015: $7.82 million | Q3 2015: $9.18 million | Q1 2016: $8.93 million | Q2 2016: $12.55 million | Q3 2016: $7.91 million | Q1 2017: $8.54 million | Q2 2017: $25.57 million | Q3 2017: $13.60 million | Q1 2018: $26.12 million | Q2 2018: $55.15 million | Q3 2018: $42.37 million | Q1 2019: $16.53 million | Q2 2019: $73.62 million | Q3 2019: $48.01 million | Q4 2019: $26.75 million | Q1 2020: $101.24 million | Q2 2020: $75.78 million | Q3 2020: $59.68 million | Q1 2021: $61.97 million | Q2 2021: $42.41 million | Q3 2021: $34.41 million | Q1 2022: $69.50 million | Q2 2022: $52.42 million | Q3 2022: $34.91 million | Q1 2023: $69.20 million | Q2 2023: $62.51 million | Q3 2023: $74.16 million | Q1 2024: $45.33 million | Q2 2024: $88.24 million | Q3 2024: $86.71 million | Q1 2025: $71.63 million | Q2 2025: $90.29 million | Q3 2025: $61.39 million.
• Over the full 16 years of available data (2010 to 2025), ADMA BIOLOGICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 38,171.2%.
• Historical annual values: Fiscal year 2025: $87.63 million | Fiscal year 2024: $103.15 million | Fiscal year 2023: $51.35 million | Fiscal year 2022: $86.52 million | Fiscal year 2021: $51.09 million | Fiscal year 2020: $55.92 million | Fiscal year 2019: $26.75 million | Fiscal year 2018: $26.75 million | Fiscal year 2017: $43.11 million | Fiscal year 2016: $9.91 million | Fiscal year 2015: $10.44 million | Fiscal year 2014: $17.20 million | Fiscal year 2013: $26.15 million | Fiscal year 2012: $12.54 million | Fiscal year 2011: $87.8 thousand | Fiscal year 2010: $229.0 thousand.
• Data sourced from SEC EDGAR public filings as of August 9, 2026.

Last verified: August 9, 2026